Buchumschlag

Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients

Methotrexate, a folic acid analog, is the conventional systemic anti-psoriatic agent most commonly chosen for combination with biologics in the treatment of psoriasis. Real-world long-term safety data of this combination versus biologic treatment alone in dermatological practice are sparse.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoffmann, Jochen (VerfasserIn) , Knoop, Christian (VerfasserIn) , Schäkel, Knut (VerfasserIn) , Enk, Alexander (VerfasserIn) , Hadaschik, Eva (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: The journal of dermatology
Year: 2021, Jahrgang: 48, Heft: 6, Pages: 835-843
ISSN:1346-8138
DOI:10.1111/1346-8138.15754
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/1346-8138.15754
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.15754
Volltext
Verfasserangaben:Jochen H.O. Hoffmann, Christian Knoop, Kunt Schäkel, Alexander H. Enk, Eva N. Hadaschik
Beschreibung
Zusammenfassung:Methotrexate, a folic acid analog, is the conventional systemic anti-psoriatic agent most commonly chosen for combination with biologics in the treatment of psoriasis. Real-world long-term safety data of this combination versus biologic treatment alone in dermatological practice are sparse.
Beschreibung:First published: 20 January 2021
Gesehen am 14.09.2021
Beschreibung:Online Resource
ISSN:1346-8138
DOI:10.1111/1346-8138.15754

Ähnliche Einträge